Azenta PE Ratio 2012-2025 | AZTA
Current and historical p/e ratio for Azenta (AZTA) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Azenta PE ratio as of January 16, 2026 is 75.47.
| Azenta PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-16 | 40.00 | 0.00 | |
| 2025-09-30 | 28.72 | $-1.30 | 0.00 |
| 2025-06-30 | 30.78 | $-2.42 | 0.00 |
| 2025-03-31 | 34.64 | $-1.39 | 0.00 |
| 2024-12-31 | 50.00 | $-2.98 | 0.00 |
| 2024-09-30 | 48.44 | $-2.97 | 0.00 |
| 2024-06-30 | 52.62 | $-2.81 | 0.00 |
| 2024-03-31 | 60.28 | $-2.71 | 0.00 |
| 2023-12-31 | 65.14 | $-0.31 | 0.00 |
| 2023-09-30 | 50.19 | $-0.18 | 0.00 |
| 2023-06-30 | 46.68 | $-0.52 | 0.00 |
| 2023-03-31 | 44.62 | $-0.63 | 0.00 |
| 2022-12-31 | 58.22 | $27.59 | 2.11 |
| 2022-09-30 | 42.86 | $28.32 | 1.51 |
| 2022-06-30 | 72.10 | $28.89 | 2.50 |
| 2022-03-31 | 82.88 | $29.55 | 2.80 |
| 2021-12-31 | 103.11 | $1.72 | 59.95 |
| 2021-09-30 | 102.26 | $1.49 | 68.63 |
| 2021-06-30 | 95.08 | $1.59 | 59.80 |
| 2021-03-31 | 81.40 | $1.25 | 65.12 |
| 2020-12-31 | 67.56 | $1.05 | 64.34 |
| 2020-09-30 | 46.00 | $0.88 | 52.27 |
| 2020-06-30 | 43.91 | $6.18 | 7.10 |
| 2020-03-31 | 30.20 | $6.09 | 4.96 |
| 2019-12-31 | 41.43 | $6.02 | 6.88 |
| 2019-09-30 | 36.47 | $6.04 | 6.04 |
| 2019-06-30 | 38.06 | $0.50 | 76.11 |
| 2019-03-31 | 28.73 | $0.72 | 39.90 |
| 2018-12-31 | 25.57 | $1.62 | 15.78 |
| 2018-09-30 | 34.08 | $1.65 | 20.66 |
| 2018-06-30 | 31.66 | $1.75 | 18.09 |
| 2018-03-31 | 26.20 | $1.68 | 15.60 |
| 2017-12-31 | 22.99 | $0.93 | 24.72 |
| 2017-09-30 | 29.14 | $0.90 | 32.38 |
| 2017-06-30 | 20.74 | $0.80 | 25.93 |
| 2017-03-31 | 21.34 | $0.67 | 31.85 |
| 2016-12-31 | 16.19 | $-0.75 | 0.00 |
| 2016-09-30 | 12.83 | $-1.02 | 0.00 |
| 2016-06-30 | 10.49 | $-1.07 | 0.00 |
| 2016-03-31 | 9.64 | $-1.08 | 0.00 |
| 2015-12-31 | 9.80 | $0.18 | 54.42 |
| 2015-09-30 | 10.65 | $0.21 | 50.70 |
| 2015-06-30 | 10.31 | $0.11 | 93.70 |
| 2015-03-31 | 10.38 | $0.36 | 28.83 |
| 2014-12-31 | 11.29 | $0.37 | 30.50 |
| 2014-09-30 | 9.22 | $0.46 | 20.05 |
| 2014-06-30 | 9.37 | $0.55 | 17.03 |
| 2014-03-31 | 9.43 | $0.21 | 44.89 |
| 2013-12-31 | 8.98 | $0.15 | 59.86 |
| 2013-09-30 | 7.91 | $-0.04 | 0.00 |
| 2013-06-30 | 8.19 | $1.64 | 4.99 |
| 2013-03-31 | 8.50 | $1.74 | 4.89 |
| 2012-12-31 | 6.67 | $1.89 | 3.53 |
| 2012-09-30 | 6.59 | $2.08 | 3.17 |
| 2012-06-30 | 7.67 | $0.50 | 15.33 |
| 2012-03-31 | 9.93 | $1.40 | 7.09 |
| 2011-12-31 | 8.21 | $1.67 | 4.92 |
| 2011-09-30 | 6.46 | $1.98 | 3.27 |
| 2011-06-30 | 8.53 | $2.17 | 3.93 |
| 2011-03-31 | 10.79 | $1.41 | 7.65 |
| 2010-12-31 | 7.13 | $1.33 | 5.36 |
| 2010-09-30 | 5.27 | $0.93 | 5.67 |
| 2010-06-30 | 6.07 | $0.32 | 18.98 |
| 2010-03-31 | 6.93 | $-0.35 | 0.00 |
| 2009-12-31 | 6.74 | $-3.11 | 0.00 |
| 2009-09-30 | 6.07 | $-3.63 | 0.00 |
| 2009-06-30 | 3.52 | $-6.85 | 0.00 |
| 2009-03-31 | 3.62 | $-6.61 | 0.00 |
| 2008-12-31 | 4.57 | $-4.31 | 0.00 |
| 2008-09-30 | 6.57 | $-3.77 | 0.00 |
| 2008-06-30 | 6.50 | $-0.34 | 0.00 |
| 2008-03-31 | 7.64 | $0.13 | 58.75 |
| 2007-12-31 | 10.38 | $1.69 | 6.14 |
| 2007-09-30 | 11.19 | $2.00 | 5.59 |
| 2007-06-30 | 14.26 | $2.24 | 6.37 |
| 2007-03-31 | 13.48 | $2.17 | 6.21 |
| 2006-12-31 | 11.32 | $0.82 | 13.80 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.840B | $0.594B |
| Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.527B | 42.25 |
| Tempus AI (TEM) | United States | $12.512B | 0.00 |
| Doximity (DOCS) | United States | $7.768B | 31.98 |
| Hims & Hers Health (HIMS) | United States | $7.144B | 58.11 |
| IRHYTHM HLDGS (IRTC) | United States | $5.386B | 0.00 |
| Hinge Health (HNGE) | United States | $3.411B | 0.00 |
| Heartflow (HTFL) | United States | $3.165B | 0.00 |
| Privia Health (PRVA) | United States | $2.868B | 179.38 |
| Inspire Medical Systems (INSP) | United States | $2.680B | 44.34 |
| 10x Genomics (TXG) | United States | $2.597B | 0.00 |
| Omnicell (OMCL) | United States | $2.267B | 46.35 |
| Enovis (ENOV) | United States | $1.371B | 7.20 |
| Clover Health Investments (CLOV) | United States | $1.312B | 0.00 |
| Schrodinger (SDGR) | United States | $1.237B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.051B | 0.00 |
| Phreesia (PHR) | United States | $0.988B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.868B | 0.00 |
| Talkspace (TALK) | United States | $0.656B | 132.00 |
| Standard BioTools (LAB) | United States | $0.600B | 0.00 |
| Claritev (CTEV) | United States | $0.503B | 0.00 |
| Evolent Health (EVH) | United States | $0.421B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.368B | 0.00 |
| Carlsmed (CARL) | United States | $0.334B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.334B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.317B | 0.00 |
| TruBridge (TBRG) | United States | $0.311B | 14.28 |
| CapsoVision (CV) | United States | $0.292B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.255B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.190B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.182B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.171B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.163B | 0.00 |
| CareCloud (CCLD) | United States | $0.123B | 6.74 |
| Outset Medical (OM) | United States | $0.096B | 0.00 |
| American Well (AMWL) | United States | $0.077B | 0.00 |
| Pulmonx (LUNG) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.072B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| 111 (YI) | China | $0.049B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.038B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.023B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| PROFUSA (PFSA) | United States | $0.009B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |